The Role of Narrow-Band Imaging Endoscopy in Diagnosing Gastric Intestinal Metaplasia

Observational: Studies in Human Beings Health Outcomes

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00673699

Enrollment

Registered

2008-05-07

Start date

2008-05-31

Completion date

2009-02-28

Last updated

2008-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyspepsia

Keywords

NBI, gastroscopy, biopsy, intestinal metaplasia

Brief summary

The purpose of this study is to determine if endoscope with NBI(narrow banding imaging)can detect intestinal metaplasia( consider pre malignant condition) and use a targeting biopsy in case of suspected intestinal metaplasia

Detailed description

To detect intestinal metaplasia which consider pre malignant condition and use a targeting biopsy in case of suspected intestinal metaplasia which allowed us to better follow-up those patients.

Interventions

PROCEDUREGastric mucosal biopsy

Using upper gastrointestinal endoscopy with targeting biopsy in patients with dyspepsia

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Dyspepsia

Exclusion criteria

* Pregnancy, * Upper gastrointestinal bleeding, * Previous gastric operation, * Known gastric malignancy' * Non cooperative patients

Design outcomes

Primary

Measure	Time frame
To determine if endoscope with NBI can detect intestinal metaplasia	In one week (the time from biopsy till the histology assement)

Countries

Israel

Contacts

Primary ContactZvi Fireman, MD

fireman@hy.health.gov.il+972-4-6304384

Backup ContactYael Kopelman, MD

yaelk@hy.health.gov.il+972-4-6304480

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026